GP's Adherence to Guidelines for Cardiovascular Disease among Elderly: A Quality Development Study

Table 2

Patients with ischemic heart disease who are pharmacologically treated and investigated according to the guidelines.

		N	Percentage (95% CI)	Difference^a (95% CI)	𝑃 value
Number of patients	2006	113
	2008	105
Investigation performed	2006	105	92.9 (86.5, 96.9)	0.54 (−8.0, 6.9)	1
	2008	97	92.4 (85.5, 96.7)
Treated with beta blocker	2006	70	61.9 (52.3, 70.9)	10.5 (−2.9,23.7)	0.14
	2008	76	72.4 (62.8, 80.7)
Treated with aspirin	2006	100	88.5 (81.1, 93.7)	−1.8 (−11.5, 7.9)	0.84
	2008	91	86.7 (78.6, 92.5)
Treated with aspirin/warfarin	2006	107	94.7 (88.8, 98.0)	−1.4 (−8.6, 5.9)	0.89
	2008	98	93.3 (86.7, 97.3)
Lipids assessed	2006	84	74.3 (65.3, 82.1)	6.6 (−5.3, 18.5)	0.31
	2008	85	81.0 (72.1, 88.0)
Target lipid level	2006	32/84	38.1 (27.7, 49.3)	9.0 (−7.1, 25.0)	0.31
	2008	40/85	47.1 (36.1, 58.2)

^a Difference between 2008 and 2006.